Since our founding in 2010, CGT Global has pursued our mission to transform healthcare as we accelerate cell and gene therapy research and clinical trials, streamline the commercialization of new treatments, and map the last mile to patient access to these life-changing remedies. By innovating each stage in the cycle; development, commercialization, and delivery, we reduce the overall cost of the care and multiply access points so that millions can receive cutting edge, life-saving gene and cell therapies.
Description
Whole human peripheral blood from Human Immunodeficiency Virus (HIV) donors is collected in sterile vacutainer tubes containing the anticoagulant EDTA. Vacutainer tubes allow for efficient and easy processing of whole blood in smaller volumes as compared to whole blood bags.
Blood was obtained using Institutional Review Board (IRB) approved consent forms and protocols.
Additional information
Weight | 1 kg |
---|---|
Anticoagulant | |
Format | |
Grade | |
Species | |
Cell and Tissue Source | |
Disease State | |
Donor Attributes |
Product Information Sheet
Certificate of Analysis
Material Safety Data Sheet
Protocols